Evidenced-based Approach to Oropharynx Cancer, 2026

Saturday, October 17, 2026

1:00 PM - 1:50 PM PT

Location: Petree Hall D

Lead Presenter(s)

NG

Neil D. Gross, MD

Professor
MD Anderson Cancer Center
Houston, Texas, United States

Co-Presenter(s)

Kathryn M. Van Abel, MD

Professor
Mayo Clinic
Rochester, MN, United States

Mentor(s)

F Christopher Holsinger, MD

Cheif of otolaryngology head and neck surgery
Stanford University School of Medicine
Stanford, California, United States

Disclosure(s):

Kathryn M. Van Abel, MD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

The incidence of HPV-associated OPSCC is one of the most common cancers diagnosed in the US. Otolaryngologists will diagnose and manage the majority of these patients. Thus, up-to-date information on the management of OPSCC is critical to the general otolaryngology community.

Learning Objectives:

To understand recent advances in the treatment of oropharynx squamous cell carcinoma (OPSCC).
To describe the current evidence supporting treatment strategies for OPSCC.
To understand the rational application of potential de-escalation strategies to OPSCC.